Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Florian Kretz, WOC 2018 – Latest Advances in IOL Technology

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Aug 28th 2018

Florian Kretz talks to touchOPHTHALMOLOGY about recent advances in IOL technology. Dr Kretz explores the difficulty in identifying patient expectation and patient need, and how the biggest challenge is bringing the technology we have available together with the needs of the patient. He also discusses advances in femtosecond lasers for cataract surgery, and how better connectivity between diagnostic devices and laser systems enhances efficiency, making the procedure faster, more reliable, more secure.

Questions:

1. What have been the most significant recent developments in the area of IOLs? (0:25)
2. What challenges do you face when treating patients with cataracts? (1:04)
3. What does the future look like for cataract surgery? (1:44)

IOL = intraocular lens

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup